Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 86% Improvement Relative Risk Ansari et al. Vitamin D for COVID-19 Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Prospective study of 125 patients in Pakistan (Mar - Aug 2020) Lower mortality with higher vitamin D levels (p=0.02) Ansari et al., Pakistan J. Med. Heal. Sci., 14:4 Favors vitamin D Favors control
Frequency of Severe Vitamin D Deficiency and its Association with Mortality in Patients with Corona virus Disease
Ansari et al., Pakistan J. Med. Heal. Sci., 14:4
Ansari et al., Frequency of Severe Vitamin D Deficiency and its Association with Mortality in Patients with Corona virus.., Pakistan J. Med. Heal. Sci., 14:4
Dec 2020   Source   PDF  
  All Studies   Meta
Prospective study of 125 severe COVID-19 patients in Pakistan, showing significantly higher mortality with vitamin D deficiency.
This is the 36th of 175 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 18 vigintillion). This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
risk of death, 86.0% lower, RR 0.14, p = 0.02, high D levels (≥25nmol/L) 2 of 68 (2.9%), low D levels (<25nmol/L) 12 of 57 (21.1%), NNT 5.5.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ansari et al., 31 Dec 2020, prospective, Pakistan, peer-reviewed, 6 authors, study period 1 March, 2020 - 31 August, 2020.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Frequency of Severe Vitamin D Deficiency and its Association with Mortality in Patients with Corona virus Disease
Dr Imdad Ali Ansari, Aneel Kumar, Tanveer Ahmed Ansari, Abrar Shaikh, Jawed Akhtar Samo
Aim: To determine the frequency of severe vitamin D deficiency and its association with mortality in patients presented with Covid-19.
Asghar, Kazmi, Ahmed, Akram, Khan et al., Clinical Profiles, Characteristics, and Outcomes of the First 100 Admitted COVID-19 Patients in Pakistan: a single-center retrospective study in a Tertiary Care Hospital of Karachi, Cureus
Baktash, Hosack, Patel, Shah, Kandiah et al., Vitamin D status and outcomes for hospitalised older patients with COVID-19, Postgrad Med J
Biesalski, Vitamin D deficiency and co-morbidities in COVID-19 patients -a fatal relationship?, NFS J
Carpagnano, Lecce, Quaranta, Zito, Buonamico et al., Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J Endocrinol Invest
Cucinotta, Vanelli, WHO Declares COVID-19 a Pandemic, Acta Biomedica: Atenei Parmensis
D'avolio, Avataneo, Manca, Cusato, Nicolo et al., 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients
Forrest, Stuhldreher, Prevalence and correlates of vitamin D deficiency in US adults, Nutr Res
Garg, Kim, Whitaker, 'halloran, Cummings et al., Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019: COVID-NET, 14 States, MMWR Morb Mortal Wkly Rep
Gheblawi, Wang, Viveiros, Nguyen, Zhong et al., Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2, Circulation Res
Grant, Lahore, Mcdonnell, Baggerly, French et al., Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths, Nutrients
Gruber-Bzura, Vitamin D and Influenza-Prevention or Therapy?, Int J Molecular Sci
Hastie, Mackay, Ho, Celis-Morales, Katikireddi et al., Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr
Huotari, Herzig, Vitamin D and living in northern latitudes -an endemic risk area for vitamin D deficiency, Int J Circumpolar Health
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res
Lamers, Beumer, Van Der Vaart, Knoops, Puschhof et al., SARS-CoV-2 productively infects human gut enterocytes, Science
Maghbooli, Sahraian, Ebrahimi, Pazoki, Kafan et al., Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection, PLoS ONE
Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data, BMJ
Ortega, Serrano, Pujol, Rangel, Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis, EXCLI journal
Owah, Fan, Dennett, Hagtvedt, Straube, Vitamin D levels and deficiency with different occupations: a systematic review, BMC Public Health
Panarese, Shahini, COVID-19, and vitamin D, Aliment Pharm Ther
Umhau, Casting sunlight on an epidemic: is vitamin D a critical host factor to prevent COVID-19?, Med Page Today
Xu, Shi, Wang, Zhang, Huang et al., Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respiratory Med
Xu, Yang, Chen, Luo, Zhang et al., Vitamin D alleviates lipopolysaccharide induced acute lung injury via regulation of the reninangiotensin system, Molecular Med Reports
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop